The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
Open accessAbstract
Although metformin is widely used for the treatment of non-insulin-dependent diabetes, its mode of action remains unclear. Here we provide evidence that its primary site of action is through a direct inhibition of complex 1 of the respiratory chain. Metformin (50 μM) inhibited mitochondrial oxidation of glutamate+malate in hepatoma cells by 13 and 30% after 24 and 60 h exposure respectively, but succinate oxidation was unaffected. Metformin also caused time-dependent inhibition of complex 1 in isolated mitochondria, whereas in sub-mitochondrial particles inhibition was immediate but required very high metformin concentrations (K0.5, 79 mM). These data are compatible with the slow membrane-potential-driven accumulation of the positively charged drug within the mitochondrial matrix leading to inhibition of complex 1. Metformin inhibition of gluconeogenesis from L-lactate in isolated rat hepatocytes was also time- and concentration-dependent, and accompanied by changes in metabolite levels similar to those induced by other inhibitors of gluconeogenesis acting on complex 1. Freeze-clamped livers from metformin-treated rats exhibited similar changes in metabolite concentrations. We conclude that the drug's pharmacological effects are mediated, at least in part, through a time-dependent, self-limiting inhibition of the respiratory chain that restrains hepatic gluconeogenesis while increasing glucose utilization in peripheral tissues. Lactic acidosis, an occasional side effect, can also be explained in this way.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metformin may cause lactic acidosis through impairment of oxidative phosphorylation.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [464]
In the citing paper
“it has been shown to accumulate in mitochondria due to the membrane potential across the mitochondrial inner membrane”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Owen et al. 2000
In the citing paper
“However, metformin, one of the commonly prescribed drugs for treating type II diabetes, is safe despite acting as a mitochondrial complex I inhibitor that impairs respiration (Bridges et al., 2014; El-Mir et al., 2000; Owen et al., 2000; Wheaton et al., 2014).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Owen et al., 2000
In the citing paper
“This inhibition would in turn decrease the ATP/AMP ratio activating AMPK (127–129).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [128]
In the citing paper
“As pointed out by Fontaine, a problem associated with accepting the argument that the therapeutic effects of metformin result from inhibition of complex 1, as depicted in Figure 1, are the high concentrations used in the cell culture studies described by El Mir et al. and Owen et al. (127, 128, 133).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [128]
In the citing paper
“Given the evidence that metformin acts through the mitochondrial electron transport chain (ETC) by inhibiting complex I(46, 210–212) (Figure 8)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [210]
Citations
Cites
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Ebert, B. L., Firth, J. D., & Ratcliffe, P. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29083 · Cited by 569
Accumulation of Metformin by Tissues of the Normal and Diabetic Mouse
Wilcock, C., & Bailey, C. J. (1994) · Xenobiotica · doi:10.3109/00498259409043220 · Cited by 418
Hundal, H. S., Ramlal, T., Reyes, R., Leiter, L. A., & Klip, A. (1992) · Endocrinology · doi:10.1210/endo.131.3.1505458 · Cited by 243
Perriello, G., Misericordia, P., Volpi, E., Santucci, A., Santucci, C., Ferrannini, E., Ventura, M. M., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1994) · Diabetes · doi:10.2337/diab.43.7.920 · Cited by 227
Argaud, D., Roth, H., Wiernsperger, N. F., & Leverve, X. M. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17886.x · Cited by 151
Biguanide-associated lactic acidosis. Case report and review of the literature
Gan, S. C. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.11.2333 · Cited by 129
Halestrap, A. P. (1987) · Biochemical Journal · doi:10.1042/bj2440159 · Cited by 120
Self-citationFischer, Y., Thomas, J., Rosen, P., & Kammermeier, H. (1995) · Endocrinology · doi:10.1210/endo.136.2.7835271 · Cited by 114
Cited by
Sorted by citations
Items 201–300 of 1,008
In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer
Momcilovic, M., Jones, A., Bailey, S. T., Waldmann, C. M., Li, R., Lee, J. T., Abdelhady, G., Gomez, A., Holloway, T., Schmid, E., et al. (2019) · Nature · doi:10.1038/s41586-019-1715-0 · Cited by 214
Role of AMP‐activated protein kinase in the metabolic syndrome and in heart disease
Hardie, D. G. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.018 · Cited by 221
Boudaba, N., Marion, A., Huet, C., Pierre, R., Viollet, B., & Foretz, M. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.01.008 · Cited by 216
Serine Catabolism Feeds NADH when Respiration Is Impaired
Yang, L., García‐Cañaveras, J. C., Chen, Z., Wang, L., Liang, L., Jang, C., Mayr, J. A., Zhang, Z., Ghergurovich, J. M., Zhan, L., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.02.017 · Cited by 216
Targeting OXPHOS and the electron transport chain in cancer; Molecular and therapeutic implications
Greene, J. P., Segaran, A., & Lord, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.002 · Cited by 215
Nesti, L., & Natali, A. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.04.009 · Cited by 211
Metformin and cancer: Doses, mechanisms and the dandelion and hormetic phenomena
Martı́n-Castillo, B., Vázquez‐Martín, A., Oliveras‐Ferraros, C., & Menéndez, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.6.10994 · Cited by 215
Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis
Griss, T., Vincent, E. E., Egnatchik, R. A., Chen, J., Ma, E. H., Faubert, B., Viollet, B., DeBerardinis, R. J., & Jones, R. G. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002309 · Cited by 216
Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes
Hallakou‐Bozec, S., Vial, G., Kergoat, M., Fouqueray, P., Bolze, S., Borel, A., Fontaine, E. M., & Moller, D. E. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14277 · Cited by 210
Bhamra, G. S., Hausenloy, D. J., Davidson, S. M., Carr, R. D., Paiva, M. S. A., Wynne, A. M., Mocanu, M. M., & Yellon, D. M. (2007) · Basic Research in Cardiology · doi:10.1007/s00395-007-0691-y · Cited by 211
Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
Hua, Y., Zheng, Y., Yao, Y., Jia, R., Ge, S., & Zhuang, A. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04263-8 · Cited by 220
Metformin-associated lactic acidosis: A prognostic and therapeutic study*
Seidowsky, A., Nseir, S., Houdret, N., & Fourrier, F. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a02490 · Cited by 205
Current understanding of metformin effect on the control of hyperglycemia in diabetes
An, H., & He, L. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0447 · Cited by 205
Metformin extends C. elegans lifespan through lysosomal pathway
Chen, J., Ou, Y., Li, Y., Hu, S., Shao, L.-W., & Liu, Y. (2017) · eLife · doi:10.7554/elife.31268 · Cited by 207
Apostolova, N., Iannantuoni, F., Gruevska, A., Muntané, J., Rocha, M., & Víctor, V. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101517 · Cited by 208
Expanding role of AMPK in endocrinology
Kola, B., Boscaro, M., Rutter, G. A., Grossman, A. B., & Korbonits, M. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.05.006 · Cited by 200
van Gisbergen, M. W., Voets, A. M., Starmans, M. H. W., de Coo, I. F. M., Yadak, R., Hoffmann, R. F., Boutros, P. C., Smeets, H. J. M., Dubois, L. J., & Lambin, P. (2015) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2015.01.001 · Cited by 207
Distinct perturbation of the translatome by the antidiabetic drug metformin
Larsson, O. S., Morita, M., Topisirović, I., Alain, T., Blouin, M., Pollak, M., & Sonenberg, N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201689109 · Cited by 205
Polyspecific organic cation transporters: their functions and interactions with drugs
Koepsell, H. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.05.005 · Cited by 198
Feng, J., Wang, X., Ye, X., Arés, I., López-Torres, B., Martínez, M., Martínez‐Larrañaga, M., Wang, X., Anadón, A., & Martínez, M. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106114 · Cited by 201
Lactic Acidosis: From Sour Milk to Septic Shock
Fall, P. J., & Szerlip, H. M. (2005) · Journal of Intensive Care Medicine · doi:10.1177/0885066605278644 · Cited by 197
Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5
Caton, P., Nayuni, N. K., Kieswich, J. E., Khan, N. Q., Yaqoob, M. M., & Corder, R. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0345 · Cited by 203
Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies
Zadra, G., Batista, J. L., & Loda, M. F. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0068 · Cited by 202
Metformin and Autoimmunity: A “New Deal” of an Old Drug
Ursini, F., Russo, E., Pellino, G., D’Angelo, S., Chiaravalloti, A., Sarro, G. D., Manfredini, R., & GIORGIO, R. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01236 · Cited by 197
Potential Therapeutic Benefits of Strategies Directed to Mitochondria
Camara, A. K. S., Lesnefsky, E. J., & Stowe, D. F. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2788 · Cited by 199
Involvement of Organic Cation Transporter 1 in the Lactic Acidosis Caused by Metformin
Wang, D., Kusuhara, H., Kato, Y., Jonker, J. W., Schinkel, A. H., & Sugiyama, Y. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.844 · Cited by 194
Kim, J., Kwak, H. J., Cha, J.-Y., Jeong, Y.-S., Rhee, S. D., Kim, K. R., & Cheon, H. G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.577908 · Cited by 197
Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer
Matassa, D. S., Amoroso, M. R., Lu, H., Avolio, R., Arzeni, D., Procaccini, C., Faicchia, D., Maddalena, F., Simeon, V., Agliarulo, I., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.39 · Cited by 198
Chakraborty, A., Adhikary, S., Bhattacharya, S., Dutta, S., Chatterjee, S., Banerjee, D., Ganguly, A., & Rajak, P. (2023) · ACS Chemical Health & Safety · doi:10.1021/acs.chas.3c00071 · Cited by 195
Mitochondrial dysfunction and complications associated with diabetes
Blake, R., & Trounce, I. A. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.11.007 · Cited by 190
Gremke, N., Polo, P., Dort, A., Schneikert, J., Elmshäuser, S., Brehm, C. U., Klingmüller, U., Schmitt, A., Reinhardt, H. C., Timofeev, O. N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18504-7 · Cited by 192
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Timm, K. N., & Tyler, D. J. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-06941-x · Cited by 192
Potential applications for biguanides in oncology
Pollak, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67232 · Cited by 194
Keeping the home fires burning: AMP-activated protein kinase
Hardie, D. G. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0774 · Cited by 195
AMP-activated protein kinase: Also regulated by ADP?
Hardie, D. G., Carling, D., & Gamblin, S. J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.06.004 · Cited by 187
Lorenzati, B., Zucco, C., Miglietta, S., Lamberti, F., & Bruno, G. (2010) · Pharmaceuticals · doi:10.3390/ph3093005 · Cited by 194
Evans, A. M., Mustard, K. J. W., Wyatt, C. N., Peers, C., Dipp, M., Kumar, P., Kinnear, N. P., & Hardie, D. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510040200 · Cited by 191
Beauloye, C., Bertrand, L., Horman, S., & Hue, L. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr034 · Cited by 191
Regulation of Snf1 Protein Kinase in Response to Environmental Stress
Hong, S. P., & Carlson, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700146200 · Cited by 184
Therapeutic targeting of cancer cell metabolism
Dang, C. V., Hamaker, M. C., Sun, P., Le, A., & Gao, P. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0730-x · Cited by 188
Algire, C., Amrein, L., Bazile, M., David, S., Zakikhani, M., & Pollak, M. (2010) · Oncogene · doi:10.1038/onc.2010.483 · Cited by 186
Alhaider, A. A., Korashy, H. M., Sayed‐Ahmed, M. M., Mobark, M., KFoury, H. M., & Mansour, M. A. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.03.014 · Cited by 181
The Role of AMPK and mTOR in Nutrient Sensing in Pancreatic β-Cells
Gleason, C. E., Lu, D., Witters, L. A., Newgard, C. B., & Birnbaum, M. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610631200 · Cited by 182
The effects of metformin on autophagy
Lu, G., Wu, Z., Shang, J., Xie, Z., Chen, C., & zhang, C. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111286 · Cited by 188
Metformin: A Hopeful Promise in Aging Research
Novelle, M. G., Ali, A., Diéguez, C., Bernier, M., & de Cabo, R. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025932 · Cited by 178
The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective
Agius, L., Ford, B. E., & Chachra, S. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093240 · Cited by 183
Hardie, D. G. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390001 · Cited by 180
Regulation of AMP-activated protein kinase by natural and synthetic activators
Hardie, D. G. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.06.002 · Cited by 180
Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer
Masoud, R., Reyes-Castellanos, G., Lac, S., Garcia, J., Dou, S., Shintu, L., Abdel Hadi, N., Gicquel, T., El Kaoutari, A., Diémé, B., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100143 · Cited by 175
Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities
Lanning, N. J., Castle, J. P., Singh, S. J., Leon, A. N., Tovar, E. A., Sanghera, A., MacKeigan, J. P., Filipp, F. V., & Graveel, C. R. (2017) · Cancer & Metabolism · doi:10.1186/s40170-017-0168-x · Cited by 175
Marchiq, I., LeFloch, R., Roux, D., Simon, M., & Pouysségur, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2260 · Cited by 182
Thyrotropin Suppression by Metformin
Vigersky, R. A., Filmore-Nassar, A., & Glass, A. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1210 · Cited by 174
Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells
Saini, N., & Yang, X. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx106 · Cited by 180
Drug-induced mitochondrial toxicity
Chan, K., Truong, D., Shangari, N., & O'Brien, P. J. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.4.655 · Cited by 176
Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk
Goldfine, A. B., & Shoelson, S. E. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88884 · Cited by 176
Gusdon, A. M., Song, K., & Qu, S. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/637027 · Cited by 172
A small molecule AMPK activator protects the heart against ischemia–reperfusion injury
Kim, A. S., Miller, E. J., Wright, T. M., Li, J., Qi, D., Atsina, K. B.-T., Zaha, V. G., Sakamoto, K., & Young, L. H. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.03.003 · Cited by 176
Molecular targeting of hypoxia in radiotherapy
Rey, S., Schito, L., Koritzinsky, M., & Wouters, B. G. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.10.002 · Cited by 178
Leclerc, I., Woltersdorf, W. W. W., Xavier, G. D. S., Rowe, R. L., Cross, S. E., Korbutt, G. S., Rajotte, R. V., Smith, R. M., & Rutter, G. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00532.2003 · Cited by 173
Tubular Injury in a Rat Model of Type 2 Diabetes Is Prevented by Metformin
Takiyama, Y., Harumi, T., Watanabe, J., Fujita, Y., Honjo, J., Shimizu, N., Makino, Y., & Haneda, M. (2011) · Diabetes · doi:10.2337/db10-0655 · Cited by 170
Cao, J., Meng, S., Chang, E., Beckwith-Fickas, K., Xiong, L., Cole, R. N., Radovick, S., Wondisford, F. E., & He, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.567271 · Cited by 173
Clarke, N. E., Belyaev, N. D., Lambert, D., & Turner, A. J. (2013) · Clinical Science · doi:10.1042/cs20130291 · Cited by 170
Caloric restriction: From soup to nuts
Spindler, S. R. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.10.003 · Cited by 169
Autophagy: A Druggable Process
Morel, É., Mehrpour, M., Botti, J., Dupont, N., Hamaï, A., Nascimbeni, A. C., & Codogno, P. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104936 · Cited by 174
Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemia
de Beauchamp, L., Himonas, E., & Helgason, G. V. (2021) · Leukemia · doi:10.1038/s41375-021-01416-w · Cited by 174
Moyle, G. J., Datta, D., Mandalia, S., Morlese, J. F., Asboe, D., & Gazzard, B. (2002) · AIDS · doi:10.1097/00002030-200207050-00005 · Cited by 168
Mitochondrial dynamics in the central regulation of metabolism
Nasrallah, C. M., & Horváth, T. L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.160 · Cited by 176
Mitochondrial Respiratory Complex I Regulates Neutrophil Activation and Severity of Lung Injury
Żmijewski, J. W., Lorne, E., Zhao, X., Tsuruta, Y., Sha, Y., Liu, G., Siegal, G. P., & Abraham, E. H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200710-1602oc · Cited by 167
Geerling, J. J., Boon, M. R., van der Zon, G. C., van den Berg, S. A. A., van den Hoek, A. M., Lombès, M., Princen, H. M. G., Havekes, L. M., Rensen, P. C. N., & Guigas, B. (2013) · Diabetes · doi:10.2337/db13-0194 · Cited by 173
The Current and Potential Therapeutic Use of Metformin—The Good Old Drug
Drzewoski, J., & Hanefeld, M. (2021) · Pharmaceuticals · doi:10.3390/ph14020122 · Cited by 173
Metformin Targets the Metabolic Achilles Heel of Human Pancreatic Cancer Stem Cells
Lonardo, E., Cioffi, M., Sancho, P., Sanchez-Ripoll, Y., Trabulo, S. M. D., Dorado, J., Balic, A., Hidalgo, M. M., & Heeschen, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076518 · Cited by 168
AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease
Wong, A., Howie, J., Petrie, J. R., & Lang, C. C. (2009) · Clinical Science · doi:10.1042/cs20080066 · Cited by 170
AMP‐activated protein kinase and cancer
Wang, W., & Guan, K. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01980.x · Cited by 167
Stimulation of AMPK prevents degeneration of photoreceptors and the retinal pigment epithelium
Xu, L., Kong, L., Wang, J., & Ash, J. D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802724115 · Cited by 165
Hernández‐Aguilera, A., Rull, A., Rodríguez‐Gallego, E., Riera-Borrull, M., Luciano‐Mateo, F., Camps, J., Menéndez, J. A., & Joven, J. (2013) · Mediators of Inflammation · doi:10.1155/2013/135698 · Cited by 167
Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth
Schöckel, L., Glasauer, A., Basit, F., Bitschar, K., Truong, H., Erdmann, G., Algire, C., Hägebarth, A., Willems, P. H., Kopitz, C., et al. (2015) · Cancer & Metabolism · doi:10.1186/s40170-015-0138-0 · Cited by 161
New mechanisms of metformin action: Focusing on mitochondria and the gut
Hur, K. Y., & Lee, M. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12328 · Cited by 161
Egnatchik, R. A., Leamy, A. K., Noguchi, Y., Shiota, M., & Young, J. D. (2014) · Metabolism · doi:10.1016/j.metabol.2013.10.009 · Cited by 161
Metformin-associated lactic acidosis in an intensive care unit
Peters, N. O., Jay, N., Barraud, D., Cravoisy, A., Nace, L., Bollaert, P., & Gibot, S. (2008) · Critical Care · doi:10.1186/cc7137 · Cited by 162
Koh, A., Mannerås-Holm, L., Yunn, N.-O., Nilsson, P. M., Ryu, S. H., Molinaro, A., Perkins, R., Smith, J. G., & Bäckhed, F. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.07.012 · Cited by 165
Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson’s Disease
Curry, D. W., Stutz, B., Andrews, Z. B., & Elsworth, J. D. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-171296 · Cited by 160
Review of Biguanide (Metformin) Toxicity
Wang, G. S., & Hoyte, C. O. (2018) · Journal of Intensive Care Medicine · doi:10.1177/0885066618793385 · Cited by 164
Arlt, W., Auchus, R. J., & Miller, W. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100040200 · Cited by 157
AMPK and NRF2: Interactive players in the same team for cellular homeostasis?
Petsouki, E., Cabrera, S. N. S., & Heiß, E. H. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.07.014 · Cited by 162
Differential effects of AMPK agonists on cell growth and metabolism
Vincent, E. E., Coelho, P. P., Blagih, J., Griss, T., Viollet, B., & Jones, R. G. (2014) · Oncogene · doi:10.1038/onc.2014.301 · Cited by 161
Xia, H., Wang, W., Crespo, J., Kryczek, I., Li, W., Wei, S., Bian, Z., Maj, T., He, M., Liu, J. R., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan4631 · Cited by 160
Thakur, S., Daley, B., Gaskins, K., Vasko, V. V., Boufraqech, M., Patel, D., Sourbier, C., Reece, J. M., Cheng, S.-Y., Kebebew, E., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3167 · Cited by 157
Stimulation of Hair Growth by Small Molecules that Activate Autophagy
Chai, M., Jiang, M., Vergnes, L., Fu, X., de Barros, S. C., Doan, N., Huang, W., Chu, J., Jiao, J., Herschman, H. R., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.070 · Cited by 158
Insulin Resistance and Mitochondrial Dysfunction
González-Franquesa, A., & Patti, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_25 · Cited by 160
Kita, Y., Takamura, T., Misu, H., Ota, T., Kurita, S., Takeshita, Y., Uno, M., Nagata, N., Kato, K., Ando, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043056 · Cited by 157
Metformin selectively targets redox control of complex I energy transduction
Cameron, A., Logie, L., Patel, K., Erhardt, S., Bacon, S., Middleton, P. K., Harthill, J. E., Forteath, C., Coats, J. T., Kerr, C., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.08.018 · Cited by 154
Cho, T., & Uetrecht, J. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00357 · Cited by 151
New Perspective for an Old Antidiabetic Drug: Metformin as Anticancer Agent
Leone, A., Gennaro, E. D., Bruzzese, F., Avallone, A., & Budillon, A. (2013) · Cancer treatment and research · doi:10.1007/978-3-642-38007-5_21 · Cited by 150
Zhuang, Y., Chan, D. K., Haugrud, A. B., & Miskimins, W. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108444 · Cited by 149
Teodoro, J. S., Nunes, S., Rolo, A. P., Reis, F., & Palmeira, C. M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01857 · Cited by 150
Guigas, B., Détaille, D., Chauvin, C., Batandier, C., Oliveira, F. D., Fontaine, E. M., & Leverve, X. M. (2004) · Biochemical Journal · doi:10.1042/bj20040885 · Cited by 153
Spatiotemporal compartmentalization of hepatic NADH and NADPH metabolism
Goodman, R. P., Calvo, S. E., & Mootha, V. K. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.tm117.000258 · Cited by 150
LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective
Ciccarese, F., Zulato, E., & Indraccolo, S. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8730816 · Cited by 147
Meng, S., Cao, J., He, Q., Xiong, L., Chang, E., Radovick, S., Wondisford, F. E., & He, L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.604421 · Cited by 146
Kim, K. H., & Lee, M.-S. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.4.245 · Cited by 146
Metadata
- Authors
- OWEN, M. R., DORAN, E., & HALESTRAP, A. P.
- Affiliations
- University of Bristol (GB)
- ORCID
- HALESTRAP, Andrew P.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2000-06-07
- Volume
- 348
- Issue
- 3
- Pages
- 607-614
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC1221104
- OpenAlex
- W1995069275
- Cited by
- 2,157
- References
- 35
- Citations by year
- 2026: 64 · 2025: 78 · 2024: 92 · 2023: 125 · 2022: 127 · 2021: 157 · 2020: 163 · 2019: 144 · 2018: 142 · 2017: 144 · 2016: 139 · 2015: 126 · 2014: 135 · 2013: 112 · 2012: 75
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Biochemical Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UWE Research Repository (UWE Bristol) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- metformin, mitochondrial complex I inhibition, mitochondrial respiratory chain, type 2 diabetes, gluconeogenesis, hepatocytes, mitochondrial membrane potential, lactic acidosis, glucose utilization, mechanism of action
- MeSH terms
- Animals, Electron Transport, Gluconeogenesis, Hypoglycemic Agents, Liver, Male, Metformin, Mitochondria, NADH, NADPH Oxidoreductases, Submitochondrial Particles, Tumor Cells, Cultured, Signal Transduction, Rats, Wistar, Electron Transport Complex I, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
